Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis

BACKGROUND: Glypican-3 (GPC3) has been widely recognized in the progression of liver tumors for several years. The relationship between overexpression of GPC3 and the poorer prognosis of patients with hepatocellular carcinoma (HCC) was performed by 2 meta-analyses. However, there were also some late...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jian, Zhang, Manka, Ma, Huimin, Song, Xincheng, He, Lingling, Ye, Xiaohui, Li, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024095/
https://www.ncbi.nlm.nih.gov/pubmed/29901640
http://dx.doi.org/10.1097/MD.0000000000011130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024095/
https://www.ncbi.nlm.nih.gov/pubmed/29901640
http://dx.doi.org/10.1097/MD.0000000000011130

Ejemplares similares